BioFlyte

About BioFlyte

BioFlyte is a company focused on biothreat security at scale, offering a revolutionary class of fieldable aerosol mass spectrometers to protect critical infrastructure and the people who use it. Their mission is to provide detection and identification of airborne hazards at the point of need.

Products & Services

Aerosol Mass Spectrometers:Fieldable devices for detecting and identifying airborne hazards such as bacteria, spores, viruses, bio-toxins, and fentanyl in real-time (within 5 minutes), with features like affordability (no expensive reagents), accuracy (validated with real-world data), and reliability (autonomous operation for months).

Specialties

Biothreat Detection Aerosol Mass Spectrometry Airborne Hazard Identification Real-time Detection Systems

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 5400000 MR: - FA: 5.4M FAN: 5400000	D: 2023-08-10 FD: 2023-08-10	3 investors

Series B Latest

2023-08-10

$5.4M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Todd Sickles

President and CEO

J

Jackie Lareau

Manager, Corporate Business Operations.

B

Bill Rule

Senior Vice President, Operations

D

Debrah Herman

Chief Financial Officer

W

Wayne Bryden, PhD

Chief Science Officer

S

Scott Pickett

Director, Customer Success

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

BioFlyte Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised